Skip to main content

Table 1 Correlations between miR-542-5p expression and the clinicopathological features of NSCLC

From: The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model

Parameters n The expression of miR-542-5p
(2-Cq)
t p
Tissue
 NSCLC 125 1.952 ± 1.507 −11.703 < 0.001*
 Adjacent lung 125 4.568 ± 1.993
Age (years)
  < 60 57 1.945 ± 1.382 −0.052 0.958
  ≥ 60 68 1.959 ± 1.615
Gender
 Male 75 1.983 ± 1.475 0.279 0.783
 Female 50 1.906 ± 1.568
Tumor size (cm)
  < 3 60 1.979 ± 1.520 0.183 0.504
  ≥ 3 65 1.928 ± 1.506
Smoking historya
 Positive 30 2.622 ± 1.510 −1.004 0.319
 Negative 38 2.266 ± 1.407
TNM stage
 I-II 54 2.822 ± 1.536 6.488 < 0.001*
 III-IV 71 1.292 ± 1.101
Lymph node metastasis
 Positive 69 1.504 ± 1.266 3.905 < 0.001*
 Negative 56 2.506 ± 1.604
Vascular invasion
 Positive 35 1.475 ± 1.305 2.247 0.026*
 Negative 90 2.138 ± 1.545
EGFR proteinb
 low 17 0.739 ± 0.407 7.753 < 0.001*
 high 40 3.049 ± 1.194
  1. n The number of patients
  2. *p < 0.05
  3. aThe data were available from 68 patients
  4. bThe data were available from 57 patients